MedTrace Logo

Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos

NCT04109846 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2026-04-24

No results posted yet for this study

Summary

To determine how often embryos reported to be abnormal by preimplantation genetic testing result in liveborn infants. To evaluate whether the pregnancies that result from these embryos are higher risk for complications and whether the resulting babies have higher risk for health or developmental issues in the first five years after birth.

Conditions

  • Aneuploidy
  • Mosaicism
  • Pregnancy Outcome

Interventions

OTHER

Non-euploid embryo transfer

Other than choice of embryo for transfer, all other medical interventions will be standard of care protocols

OTHER

Euploid Transfer

Standard of Care Protocol

Sponsors & Collaborators

Principal Investigators

  • Ruth Lathi, MD · Stanford University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-11
Primary Completion
2035-04-30
Completion
2039-04-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04109846 on ClinicalTrials.gov